"alpha-Fetoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first alpha-globulins to appear in mammalian sera during FETAL DEVELOPMENT and the dominant serum proteins in early embryonic life.
| Descriptor ID |
D000509
|
| MeSH Number(s) |
D12.776.124.790.106.092 D12.776.320.525.500 D12.776.377.228.500 D12.776.377.715.085.092 D23.101.140.050
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "alpha-Fetoproteins".
Below are MeSH descriptors whose meaning is more specific than "alpha-Fetoproteins".
This graph shows the total number of publications written about "alpha-Fetoproteins" by people in this website by year, and whether "alpha-Fetoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 4 | 7 | 11 |
| 2018 | 7 | 11 | 18 |
| 2019 | 2 | 3 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "alpha-Fetoproteins" by people in Profiles.
-
Clinical significance and molecular mechanism of angiotensin-converting enzyme 2 in hepatocellular carcinoma tissues. Bioengineered. 2021 12; 12(1):4054-4069.
-
Effect of the coronavirus pandemic on tumor markers. J Med Virol. 2021 Sep; 93(9):5405-5408.
-
Mediastinal germ cell tumour during the COVID-19 pandemic. BMJ Case Rep. 2020 07 08; 13(7).
-
Surveillance and Monitoring of Hepatocellular Carcinoma During the COVID-19 Pandemic. Clin Gastroenterol Hepatol. 2021 08; 19(8):1520-1530.
-
Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma. Anal Bioanal Chem. 2019 May; 411(14):3009-3019.
-
Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of a-fetoprotein. Lancet Oncol. 2019 04; 20(4):e191.
-
More Than Just Wait Time? Regional Differences in Liver Transplant Outcomes for Hepatocellular Carcinoma. Transplantation. 2019 04; 103(4):747-754.
-
Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased a-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019 02; 20(2):282-296.
-
Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt. Endocr Metab Immune Disord Drug Targets. 2019; 19(7):1005-1011.
-
Specific prognostic factors in hepatitis B virus-related and non-hepatitis B virus-related intrahepatic cholangiocarcinoma after macroscopic curative resection. J Surg Oncol. 2019 Jan; 119(1):40-46.